Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
An entity connected to SharkNinja, Inc. director Wang Xuning has completed a substantial sale of company shares, raising over $400 million. The transaction occurs as the household appliance manufacturer's stock approaches its highest point in the past year, coinciding with recent analyst upgrades and the introduction of a new premium hair styling d…
Jon Halbert, a director at Caris Life Sciences, Inc. (NASDAQ: CAI), has executed a significant insider purchase, acquiring 68,000 shares of the company's common stock on May 15, 2026. The transaction, valued at $990,080, was facilitated through LAH Investments, Ltd., and reflects a weighted average purchase price of $14.56 per share. This acquisiti…
Gregory A. Sandfort, a director at Genesco Inc. (NYSE:GCO), has increased his stake in the company through a recent purchase of 2,958 shares. The transaction, executed on July 9, 2026, valued at $33.80 per share, totals $99,980. This acquisition price matches InvestingPro’s Fair Value for the stock, suggesting the director views the current valuati…
Mark H. Rachesky, a ten percent owner and director at Lionsgate Studios Corp. (NASDAQ: LION), has executed a substantial series of indirect share transfers through a continuation fund transaction, according to an SEC Form 4 filing dated July 8, 2026. The restructuring involved the movement of over 85 million shares across multiple affiliated entiti…
Mina Rezk, the Chief Technology Officer and director at Aeva Technologies, Inc. (NASDAQ: AEVA), executed a non-discretionary sale of 64,821 shares on July 8, 2026. The transaction, valued at $1,371,897, was triggered by the vesting of time-based restricted stock units and was specifically designated to satisfy tax withholding obligations. This auto…
Saurabh Sinha, serving as the Chief Financial Officer for Aeva Technologies, Inc., executed a sale of 20,620 shares of the company's common stock on July 8, 2026. This transaction, valued at approximately $436,409, involved shares sold at $21.1644 each. The sale was classified as a non-discretionary transaction, specifically intended to cover tax w…
Aeva Technologies Inc. (NASDAQ: AEVA) Chief Executive Officer Soroush Salehian Dardashti executed a sale of 64,821 common shares on July 8, 2026, generating approximately $1,371,897. The transaction occurred at a per-share price of $21.1644 and was classified as an automatic, non-discretionary sale intended to cover tax withholding requirements ass…
Eliyahou Harari, a significant shareholder holding a 10% stake in CapsoVision, Inc. (CV), executed a substantial equity purchase on July 8, 2026, according to Securities and Exchange Commission filings. The transaction involved the acquisition of 81,300 shares at $6.09 per share, totaling $495,117. This purchase price exceeds the stock's prevailing…
Apogee Therapeutics CEO Michael Henderson sold 20,000 shares worth $2.67 million on July 8, 2026, under a pre-existing trading plan. The transaction coincides with the company's pending acquisition by AbbVie for $135.11 per share in cash, valuing Apogee at approximately $10.9 billion. Following the acquisition announcement, several analysts have ad…
Divesh Makan, serving as a managing member of ICONIQ Parent GP VIII, alongside affiliated entities including ICONIQ Strategic Partners VIII Holdings, L.P., ICONIQ Strategic Partners VIII GP, L.P., and ICONIQ Strategic Partners VIII TT GP, LLC, has executed a substantial acquisition of Netskope Inc (NASDAQ:NTSK) Class A Common Stock. The collective …
William J.G. Griffith, a director and significant shareholder of Netskope Inc., has executed a substantial indirect purchase of the cybersecurity firm's Class A Common Stock. The transaction, valued at approximately $7.2 million, highlights continued institutional interest in Netskope as the company navigates a competitive market landscape. This ac…
David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics (NASDAQ: MLYS), executed a series of transactions on July 9, 2026, involving the sale of 2,171 shares and the exercise of an equivalent number of stock options. The sale, conducted under a pre-established Rule 10b5-1 trading plan, resulted in proceeds of $65,781 at a price of $30.…
Nagendran Sukumar, President and Head of Research & Development at Taysha Gene Therapies, Inc. (NASDAQ:TSHA), sold 200,000 shares of the company’s common stock on July 10, 2026. The transaction, valued at $1,248,000, was executed under a Rule 10b5-1 trading plan established on June 11, 2025. This sale reduces Sukumar's direct holdings to 936,410 sh…
Gayla J. Delly, serving in a directorial capacity at Broadcom Inc. (NASDAQ:AVGO), executed a sale of 1,890 shares of the company's common stock on July 8, 2026. The transaction resulted in proceeds totaling $728,368, with each share disposed of at a price of $385.38. This insider activity takes place against a backdrop of significant corporate deve…
Mark David Brazeal, Broadcom Inc.'s Chief Legal and Corporate Affairs Officer, executed a significant stock sale on July 8, 2026, offloading 25,000 shares valued at approximately $9.48 million. The transaction occurred as Broadcom continues to solidify its position in the semiconductor industry through major partnerships and financial maneuvers. Wh…
Thrivent Financial for Lutherans, a major shareholder holding approximately 10% of Gloo Holdings, Inc., has executed a series of sales totaling roughly $496,025 in Class A Common Stock. The divestment occurred over a three-day window in early July 2026, with the organization selling 158,000 shares across varying price points. This activity coincide…
SRB Corp, a subsidiary of Plymouth Rock Co Inc, and Plymouth Rock Co Inc jointly reported the sale of 2,650 shares of Safety Insurance Group Inc. (NASDAQ:SAFT) common stock on July 9, 2026. The transaction, valued at $202,754, reflects a sale price of $76.5110 per share. Following this disposition, the reporting entities retain a collective holding…
Jay W. Roth, CEO and Chairman of Venu Holding Corp (NASDAQ: VENU), executed a purchase of 7,850 shares on July 9, 2026, totaling $19,910 at $2.5364 per share. The acquisition brings Roth's direct share count to 9,263,114, with additional indirect beneficial ownership through two living trusts. This transaction occurs as Venu's stock trades near its…
Seer, Inc. (NASDAQ:SEER) director Nishar Dipchand sold 10,660 shares of the company's Class A Common Stock on July 8, 2026, generating approximately $23,265. The transaction, executed under a Rule 10b5-1 trading plan adopted on August 8, 2025, was intended to cover tax liabilities from restricted stock unit vesting. The sale occurred as SEER stock …
Affiliates of Silver Lake, including director Egon Durban, reported selling approximately $26.95 million worth of Dell Technologies (DELL) Class C Common Stock on July 8, 2026. The transactions involve 63,095 shares sold at prices between $420.21 and $438.00 per share. The sales occur as Dell shares trade near $434.83, reflecting significant recent…
David M. Carter, President of the DRSS Division at Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), completed a stock sale totaling $201,818 on July 8, 2026. The transaction involved the disposal of 4,000 shares executed under a pre-arranged 10b5-1 trading plan adopted in June 2025. This executive activity occurs against a backdrop of broad…
BioCardia Inc. (NASDAQ:BCDA) President and CEO Peter Altman has increased his direct ownership by acquiring 7,500 shares over three consecutive days in early July 2026. The insider buying activity occurs as the company navigates critical regulatory pathways for its CardiAMP Cell Therapy and has recently secured approximately $4.5 million in capital…
Mark Hancock, a director and ten percent owner of PACS Group, Inc. (NASDAQ:PACS), recently executed a series of stock transactions totaling approximately $1.14 million. The sales were conducted over two consecutive days in July 2026 under a pre-existing Rule 10b5-1 trading plan. This activity takes place as PACS Group trades near its 52-week high o…
Joshua M. Eizen, serving as both Chief Operating Officer and Chief Legal Officer at AN2 Therapeutics, Inc. (NASDAQ: ANTX), executed a sale of 5,945 shares of the company's common stock on July 8, 2026. The transaction, valued at $24,802, was conducted at a price of $4.172 per share. This disposition was not a discretionary exit but rather a mandato…
BitGo Holdings, Inc. (NASDAQ: BTGO) Chief Financial Officer Edward Reginelli has executed several transactions involving the company's Class A Common Stock, primarily structured to satisfy tax withholding obligations. These sales coincide with a period where the stock has experienced significant volatility, trading near its 52-week lows. Concurrent…
